Diagnostics plays Guardant, Exosome close private rounds

Two companies in the minimally invasive, fluid-based diagnostics sector announced private funding rounds on Thursday.

Guardant Health Inc. (Redwood City, Calif.) said it raised the majority of a planned $100 million series D round. New investor OrbiMed led the close, which comprised a mixture of equity and a term loan facility. Existing investors Khosla Ventures, Sequoia Capital, Lightspeed Venture Partners, Pejman Mar, Formation 8 and Heritage Group also participated. ...